Phenotype–genotype network construction and characterization: a case study of cardiovascular diseases and associated non-coding RNAs
暂无分享,去创建一个
Bairong Shen | Yuxin Lin | Xingyun Liu | Rongrong Wu | Chaoying Zhan | Hongxin He | Manhong Shi | Zhi Jiang | Hongxing He | Bairong Shen | Zhi Jiang | Yuxin Lin | Manhong Shi | Rongrong Wu | Chaoying Zhan | Xingyun Liu | Hongxin He | Rongrong Wu | Xingyun Liu | Zhi Jiang | Bairong Shen | Bairong Shen | Hongxin He | Manhong Shi | Zhi Jiang
[1] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[2] T Cooper Woods,et al. Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels , 2017, Circulation. Cardiovascular genetics.
[3] Lu Zhang,et al. The circular RNA MICRA for risk stratification after myocardial infarction☆ , 2017, International journal of cardiology. Heart & vasculature.
[4] J. Mattick,et al. Non‐coding RNAs: regulators of disease , 2010, The Journal of pathology.
[5] Ciro Indolfi,et al. Non-Coding RNAs: The “Dark Matter” of Cardiovascular Pathophysiology , 2013, International journal of molecular sciences.
[6] Qin Lin,et al. HDncRNA: a comprehensive database of non-coding RNAs associated with heart diseases , 2018, Database J. Biol. Databases Curation.
[7] Bairong Shen,et al. MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery , 2018, RNA biology.
[8] Jie Wu,et al. deepBase v2.0: identification, expression, evolution and function of small RNAs, LncRNAs and circular RNAs from deep-sequencing data , 2015, Nucleic Acids Res..
[9] A. Blaes,et al. Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.
[10] Jiajia Chen,et al. Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data , 2015, BMC Genomics.
[11] Ning Zhang,et al. The Long Non-Coding RNA SNHG1 Attenuates Cell Apoptosis by Regulating miR-195 and BCL2-Like Protein 2 in Human Cardiomyocytes , 2018, Cellular Physiology and Biochemistry.
[12] Hong Cheng,et al. Long non-coding RNA RMST silencing protects against middle cerebral artery occlusion (MCAO)-induced ischemic stroke. , 2018, Biochemical and biophysical research communications.
[13] Thomas Thum,et al. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury. , 2017, Circulation research.
[14] Zhen Yang,et al. LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases , 2018, Nucleic Acids Res..
[15] Chen Chen,et al. Identification of cardiac long non-coding RNA profile in human dilated cardiomyopathy , 2018, Cardiovascular research.
[16] Yang Gao,et al. CSCD: a database for cancer-specific circular RNAs , 2017, Nucleic Acids Res..
[17] Yan Li,et al. circRNADb: A comprehensive database for human circular RNAs with protein-coding annotations , 2016, Scientific Reports.
[18] P. Pandolfi,et al. The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.
[19] J. Mattick,et al. Non-coding RNA. , 2006, Human molecular genetics.
[20] Frank Rühle,et al. Long non-coding RNA Databases in Cardiovascular Research , 2016, Genom. Proteom. Bioinform..
[21] Jing Xu,et al. Differential Expression of CircRNAs in Embryonic Heart Tissue Associated with Ventricular Septal Defect , 2018, International journal of medical sciences.
[22] Bin Li,et al. Effects of Atorvastatin on Th polarization in patients with acute myocardial infarction , 2005, European journal of heart failure.
[23] M. Kiriakidou,et al. An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation , 2007, Cell.
[24] Mansi Arora,et al. Human coronary heart disease: importance of blood cellular miR-2909 RNomics , 2014, Molecular and Cellular Biochemistry.
[25] Albert,et al. Emergence of scaling in random networks , 1999, Science.
[26] Petar Glažar,et al. circBase: a database for circular RNAs , 2014, RNA.
[27] Daihiko Hakuno,et al. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol , 2017, Circulation research.
[28] P. Camici,et al. The role of T and B cells in human atherosclerosis and atherothrombosis , 2015, Clinical and experimental immunology.
[29] Teresa M. Przytycka,et al. Understanding Genotype-Phenotype Effects in Cancer via Network Approaches , 2016, PLoS Comput. Biol..
[30] Yan Lin,et al. DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements , 2013, Nucleic Acids Res..
[31] Myoung-Hee Kim,et al. Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease , 2017, Medicine.
[32] P. Pandolfi,et al. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.
[33] Jiajia Chen,et al. MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model , 2015, Oncotarget.
[34] Wei Chen,et al. ECharts: A declarative framework for rapid construction of web-based visualization , 2018, Vis. Informatics.
[35] Lei Zhang,et al. MIAT promotes proliferation and hinders apoptosis by modulating miR-181b/STAT3 axis in ox-LDL-induced atherosclerosis cell models. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[36] David I. K. Martin,et al. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Fernández-Hernando,et al. Noncoding RNAs and Atherosclerosis , 2014, Current Atherosclerosis Reports.
[38] Lu Zhang,et al. A heart-enriched antisense long non-coding RNA regulates the balance between cardiac and skeletal muscle triadin. , 2018, Biochimica et biophysica acta. Molecular cell research.
[39] T. Gaziano,et al. Cardiovascular Disease in the Developing World and Its Cost-Effective Management , 2005, Circulation.
[40] Michael Q. Zhang,et al. NONCODEV5: a comprehensive annotation database for long non-coding RNAs , 2017, Nucleic Acids Res..
[41] Jiajia Chen,et al. Computational analysis of microRNA function in heart development. , 2010, Acta biochimica et biophysica Sinica.
[42] L. Harries,et al. Long non-coding RNAs and human disease. , 2012, Biochemical Society transactions.
[43] Ana Kozomara,et al. miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..
[44] David Erlinge,et al. MicroRNAs in the failing heart – Novel therapeutic targets? , 2014, Scandinavian cardiovascular journal : SCJ.
[45] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[46] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[47] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[48] Trey Ideker,et al. Genotype to phenotype via network analysis. , 2013, Current opinion in genetics & development.
[49] R. Frye,et al. Molecular Fingerprint of Interferon-&ggr; Signaling in Unstable Angina , 2001, Circulation.
[50] Bairong Shen,et al. Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network , 2015, Oncotarget.
[51] A. Keller,et al. Distribution of miRNA expression across human tissues , 2016, Nucleic acids research.
[52] Natasha Shroff,et al. Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke , 2016, Neurology.
[53] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[54] Koh Ono,et al. MicroRNAs and cardiovascular diseases , 2011, The FEBS journal.
[55] E. Olson,et al. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles , 2012, Nature Reviews Drug Discovery.
[56] Mark E. J. Newman,et al. Power-Law Distributions in Empirical Data , 2007, SIAM Rev..
[57] Marcel E. Dinger,et al. lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs , 2014, Nucleic Acids Res..
[58] Sercan Ergün,et al. Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy , 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[59] Hong-Yu Ou,et al. EG: a database of essential genes , 2004, Nucleic Acids Res..
[60] Bing Han,et al. Circular RNA DLGAP4 Ameliorates Ischemic Stroke Outcomes by Targeting miR-143 to Regulate Endothelial-Mesenchymal Transition Associated with Blood–Brain Barrier Integrity , 2018, The Journal of Neuroscience.
[61] Fanming Meng,et al. Expression status and clinical significance of lncRNA APPAT in the progression of atherosclerosis , 2018, PeerJ.
[62] Thomas Thum,et al. Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment–Elevation Myocardial Infarction: Role of Differential MicroRNA-378 Expression , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[63] E. Olson,et al. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. , 2007, The Journal of clinical investigation.
[64] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[65] I. Jurisica,et al. NAViGaTing the Micronome – Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAs , 2011, PloS one.
[66] M. Mann,et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans , 2016, Nature Communications.
[67] Igor Jurisica,et al. mirDIP 4.1—integrative database of human microRNA target predictions , 2017, Nucleic Acids Res..
[68] Xiaoqian Jiang,et al. Novel Biomarker MicroRNAs for Subtyping of Acute Coronary Syndrome: A Bioinformatics Approach , 2016, BioMed research international.
[69] Artemis G. Hatzigeorgiou,et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions , 2017, Nucleic Acids Res..
[70] Thomas Thum,et al. Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy. , 2016, American journal of physiology. Heart and circulatory physiology.
[71] Sheng-Shou Hu,et al. China cardiovascular diseases report 2015: a summary , 2017, Journal of geriatric cardiology : JGC.
[72] Francesca N. Delling,et al. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.
[73] J. Mattick,et al. Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.
[74] K. Kiura,et al. Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC) , 2017, Internal medicine.
[75] Lawrence H Kushi,et al. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study , 2018, Journal of Cancer Survivorship.
[76] Sen Yan,et al. The MALAT1 gene polymorphism and its relationship with the onset of congenital heart disease in Chinese , 2018, Bioscience reports.
[77] François M Abboud,et al. Autonomic regulation of the immune system in cardiovascular diseases. , 2017, Advances in physiology education.
[78] Jiajia Chen,et al. Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis , 2013, Journal of Translational Medicine.
[79] Tao Zhou,et al. LncRNA XIST regulates myocardial infarction by targeting miR‐130a‐3p , 2019, Journal of cellular physiology.
[80] Li Wang,et al. Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers , 2018, Nucleic Acids Res..
[81] Hongchuan Jin,et al. MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges , 2015, BioMed research international.
[82] Hsien-Da Huang,et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions , 2017, Nucleic Acids Res..
[83] Nan Wan,et al. miR-873 suppresses H9C2 cardiomyocyte proliferation by targeting GLI1. , 2017, Gene.
[84] Gajendra P. S. Raghava,et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs , 2013, Database J. Biol. Databases Curation.
[85] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[86] Tongbin Li,et al. miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..
[87] M. Gulati,et al. The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease , 2018, Clinical cardiology.
[88] Haiyun Wang,et al. Pathway analysis of microRNAs in mouse heart development , 2010, Int. J. Bioinform. Res. Appl..